Jae Park

33PUBLICATIONS
286CO-AUTHORS
Carbon capture engineering (excl. sequestration)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Rheumatology and arthritisHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Oct 20, 2026
The EF1α promoter of cilta-cel drives a highly effective GZMK+ transcriptional program.

|Aug 31, 2026
Tumor CD19 Expression Determines Distinct Clinical Outcomes after CD19 CAR T-cell Therapy in Large B-cell Lymphoma.

|Aug 25, 2026
Outpatient Treatment-Related Toxicity After Hospital Discharge Among Patients Receiving Lifileucel for Advanced Melanoma.

|Aug 11, 2026
Optimizing safety and efficacy of asparaginase and blinatumomab therapy in frontline acute lymphoblastic leukemia regimens in diverse health care settings-international expert consensus.

|Jul 17, 2026
Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia.

|Jul 15, 2026
IL7-Receptor-Targeted CAR T-Cell Therapy for T-Cell Acute Lymphoblastic Leukemia.

Pageof 6

Frequent Collaborators

12 joint publications

Maria Lia Palomba

11 joint publications

Miguel-Angel Perales

10 joint publications

Gilles Salles

9 joint publications

Gunjan Shah